SR-4995 OPTIONS

Inside the multiday, multiple-dose arm, baseline microbiota was similar among topics that acquired ibezapolstat compared with vancomycin. At Day 10 of dosing, differential abundance Assessment and β-diversity demonstrated a distinct difference between the microbiome in topics offered vancomycin when compared with possibly dose of ibezapolstat (Hor